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EDITORIAL 
The Keratinocyte Has Become the Subject of Intensive Investigation 
There has been an explosive growth of information on the 
distribution, structure, and synthesis of the fibrous keratin 
polypeptides brought about by the application of the new 
techniques of molecular biology to studies of epithelial tissue. 
It has been shown that keratins are a family of neutral buffer-
insoluble polypeptides of molecular weight 40,000- 70,000 which 
are characteristic of epithelial tissue [1-3]. The most effective 
method for identifying the polypeptides has been 2-dimensional 
electrophoresis using isoelectric focusing in the first direction 
and sodium dodecyl sulfate (SDS) polyacrylamide gel electro-
phoresis (PAGE) in the second. At least 19 different polypep-
tides have been described, but distinct patterns consisting of 
fewer polypeptides are observed in specific tissues. Keratins of 
different size possess certain common structural features but 
the greater their difference in size the more they diverge in 
structure [ 4]. That these structural differences are encoded in 
their genes rather than being related to posttranslational mod-
ifications has been shown by studies with cloned eDNA probes 
[5]. 
It has been possible to classify the keratin polypeptides 
present in epithelial tissue according to whether it is simple, 
stratified, or keratinized [6]. Epidermis contains the 67 kd and 
56 kd polypeptides which are markers of keratinizing tissue as 
well as the 50 and 58 kd polypeptides characteristic of stratified 
epithelium. Certain keratin polypeptides are synthesized in 
different layers of the epidermis- the 56 and 67 kd polypeptides 
in suprabasal cells and the 50 and 58 kd polypeptides in the 
basal layer. Monoclonal antibodies have been helpful in these 
stu!fies, but those presently available are not specific for a 
particular polypeptide. Studies with mRNA isolated from epi-
dermis and cultured cells have demonstrated that products 
synthesized in vitro closely match the keratin polypeptides 
found in vivo [7]. They have also revealed that degradation of 
polypeptides occurs in the stratum corneum. 
The use of cloned eDNA probes has shown that there are 
separate genes for at least some and probably most of the 
keratins and that they can be grouped according to similarities 
in the size of the polypeptides whose synthesis they direct. It 
has been possible to obtain almost complete sequence data on 
some keratin polypeptides, leading to a greater understanding 
of molecular structure [8]; helical and nonhelical regions exist 
and it may be that the latter are responsible for the major 
variability found among different polypeptides. Furthermore, 
differences in the length or position of the helical segments 
could be important for the association of different polypeptides 
and this could explain the different cytoskeletal protein com-
positions of the various strata of the epidermis. Several inves-
tigators have proposed that the epidermal keratin molecule 
consists of three polypeptide chains, which is in contrast to the 
double-stranded model proposed by the wool chemists. New 
data on epidermal keratins, however, suggest that the previous 
interpretations may have been incorrect and that the basic unit 
of fibrous protein in epidermis may also contain two polypep-
t ide chains. 
Epidermal cell culture has proved very valuable for studying 
fibrous proteins. Stratified cultured cells make different poly-
peptides than does whole tissue but show no variation of 
polypeptides in different layers. They do not synthesize the 67 
kd polypeptide, but the presence of the 56 kd one indicates that 
t hese cells are not identical in composition to epidermal basal 
cells. When cells of different epithelial origin (e.g. , rabbit 
cornea, esophagus, and skin, which have different keratin poly-
peptide patterns) are cultured, they show similar (although not 
identical) patterns and these are different than those of the 
starting tissue [9]. If these cultured cells are then transplanted 
to nude mice they develop the morphologic features of, and 
synthesize the same keratin patterns as, the starting tissues. 
These studies indicate that the tissues have an intrinsic diver-
gence in vivo, but that this can be reversibily modulated to 
some degree by extrinsic environmental factors. The effect of 
vitamin A is also an example of this type of regulation. When 
present in the medium of cultured cells the 67 kd polypeptide 
is not synthesized, while it is made in its absence. 
The finding of multiple components of the same weight 
keratin in 2-dimensional electrophoretic patterns suggested the 
possibility of posttranslational modification of the polypep-
tides. That polypeptides could be differentially labeled with 
phosphate pointed to phosphorylation as part of the explana-
tion [10]. Phosphate was found primarily in serine residues in 
the nonhelical regions of the molecule and the phosphate 
content was identical in the proteins of the living layer and 
stratum corneum. Since an effect of phosphate on polypeptide 
assembly could not be demonstrated, a possible role for phos-
phate groups could be in the interaction of the fibrous keratins 
with keratohyalin basic protein. 
The keratin polypeptide pattern is altered in psoriasis with 
loss of the 67 kd polypeptide in affected epidermis [11] and its 
return to normal after treatment [12]. This change is not 
entirely specific, having been observed in other chronic diseases 
of the epidermis such as eczematous dermatitis. A characteristic 
electrophoretic pattern has been observed in human basal cell 
carcinomas, which is very similar to that of cultured human 
epidermal cells [13] . Abnormalities of fibrous proteins have 
also been observed in epidermolytic hyperkeratosis but the 
changes were not consistent. 
Cultured keratinocytes appear to hold great promise for 
studying disorders of keratinization, but studies of cultured 
psoriatic keratinocytes so far have failed to show a difference 
from normal cells [14] . However, the cells were not grown 
under optimal conditions for enhancing differentiation (e.g., 
low vitamin A content). Organ cultures of skin from patients 
with Darier's disease and Hailey-Hailey disease grown with 
small amounts of serum have shown typical acantholysis and 
the culture medium could induce similar changes in normal 
cells, which suggested a proteolytic enzyme was produced [15]. 
Preliminary tissue culture studies using keratinocytes from 
other hereditary blistering diseases of the epidermis have failed 
to show the characteristic morphologic changes, but serum-free 
medium was not used and this may be necessary to allow the 
pathologic changes to be expressed. 
Grafting of diseased skin onto nude mice has provided new 
insights into psoriasis where affected skin continues to show 
papillomatosis and an elevated labeling index, while unaffected 
skin shows an elevated labeling index and subtle changes in 
morphology [16]. An elevation of plasminogen activator has 
also been reported in transplanted uninvolved psoriatic epider-
mis [17]. The SDS PAGE patterns of keratin polypeptides in 
the arafted skin have not been studied and it would be of inter~st to learn whether unaffected skin that has increased 
cell kinetics shows a pattern typical of psoriatic epidermis. 
Although use of cultured keratinocytes alone may have limited 
usefulness for studying psoriasis, combining such cells with 
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natural or artificial dermis and then grafting this onto nude 
mice may prove very helpful. This might be useful in determin-
ing whether t he epidermis is the site of the defect and provide 
a larger supply of cells for study. 
Keratohyalin is composed of histidine-rich proteins which 
are synthesized in the upper spinous and granular layers. The 
proteins have been most completely characterized in the new-
born rat where a basic protein, now called filaggrin, was isolated 
from the stratum corneum. A phosphorylated precursor of 
53,000 daltons was identified, but further studies led to the 
discovery of a high-molecular-weight precursor (>200,000 dal-
tons) which was broken down by proteolysis [18,19]. Filaggrins 
have been identified in a number of animals including humans, 
but they vary in molecular weight. These basic proteins func-
tion as a matrix material for the fibrous protein and are 
responsible fo r organizing it into the supramolecular bundles 
so characterist ic of the stratum corneum [20] . This complex 
appears to dissociate in the upper layers of the stratum corneum 
as a result of conversions of arginine to citrulline residues in 
filaggrin and its progressive breakdown to free amino acids. 
The metabolic pathway of human filaggrin appears to he similar 
to that of other animals but it is not clear whether it is 
completely degraded. 
The cornified envelope (marginal hand) of stratum corneum 
is located underneath the plasma membrane and is insoluble 
in denaturing solvents and resists complete proteolytic diges-
tion because off-( -y-glutamyl)cross-links (21]. Chemical studies 
have suggested it is rich in cystine but the methods used for 
preparation of the envelopes very likely degraded them. Soluble 
precursors of different s ize have been reported in several species 
(involucrin , keratolynin) and these are thought to be cross-
linked by t he enzyme t ransglutaminase at the base of the 
stratum corneum to yield the cornified envelopes (22,23]. Reg-
ulation of envelope formation and transglutaminase activity 
have been studied in cultured keratinoyctes and appear to vary 
with source of keratinocytes and culture system [24]. Therefore 
one must be cautious in extrapolating the results of in vitro 
studies to the in vivo situation. Major problems that need to 
be studied include t he identification of new envelope precur-
so rs, development of techniques for isolating envelopes which 
do not cause protein degradation, and demonstration of dis-
turbances of envelope synthesis in diseases. 
The identificat ion of peptide-bound citrulline in hair proteins 
led to the demonstration of an enzyme, peptidyl arginine deim-
inase, which catalyzes t he deimination of the guanidyl groups 
to ureido group with loss of ammonia [25]. A similar enzyme 
has been found in epidermis, skeletal muscle, and brain, where 
immunologic, physical, and kinetic properties of the purified 
enzyme have been described [26]. Epidermal substrates for the 
enzyme include filaggrin, cornified envelope, and fibrous poly-
peptides. Peptidyl arginine deiminase is a marker for the ter-
minal stages of keratinization, but its total function has not 
been defined . It may play a role in modifying regulatory proteins 
such as enzymes (e.g., transglutarninase) in addition to struc-
tural proteins. 
The structural proteins of the desmosome have proved to be 
t he most difficult to isolate. Skerrow and Matoltsy were the 
first to report the preparation of a desmosomal-enriched frac-
tion from epidermis and showed it consisted of a mixture of 
proteins of diverse molecular weight. Gorbsky and Steinberg 
[27] improved the isolation technique and identified two non-
glycosolated proteins with molecular weights of 205,000 and 
230,000 which they suggested might be located in the desmo-
somal plaque, and glycosolated components of molecular 
weights 150,000, 115,000 and 100,000 which were considered to 
be present in the intercellular cross-bridges. Mueller and 
Franke [28) convincingly demonstrated that the two large-
molecular-weightcomponents (desmoplakins I and II) were the 
major structural polypeptides of the desmosomal plaque using 
immunoelectron microscopy. The desmoplakins were found to 
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consist of isoelectric variants including some labeled with (32P] 
phosphate. They have further demonstrated that the desmo-
plakins were the major constituents of desmosomal plaques of 
epithelial cells of a number of species. It remains to be shown 
precisely how the filaments are attached to the plaques and the 
distribution of the various glycoproteins in the different regions 
of the intercellular bridges. 
Considerable progress has been made in our understanding 
of the structural proteins of epidermis but this continues to be 
an exciting and fruitful field for research. As our knowledge of 
chemistry and structure becomes more complete it should be 
possible to develop a more comprehensive picture of how the 
various components are organized into the complex process of 
keratinization . This should lead to a more complete under-
standing of the pathologic events that occur in the epidermis 
and more rational therapy for many diseases. 
Howard P. Baden, M.D. 
Harvard Medical School 
Massachusetts General Hospital 
Boston, Massachusetts 
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